FIG 6. Relationship between normalized rCBV ratios in patients with tumor recurrence and those with nonneoplastic contrast-enhancing tissue
FIG 6. Relationship between normalized rCBV ratios in patients with tumor recurrence and those with nonneoplastic contrast-enhancing tissue